Acute renal failure due to immune reconstitution inflammatory interstitial nephritis in an HIV-positive patient |
|
B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection |
|
British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013. |
|
A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection. |
|
A comparison between two strategies for monitoring hepatic function during antituberculous therapy |
|
Comparison of screening strategies to improve the diagnosis of latent tuberculosis infection in the HIV-positive population: a cohort study |
|
Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01 |
|
The effect of tenofovir on vitamin D metabolism in HIV-infected adults is dependent on sex and ethnicity |
|
Effect of the HIV epidemic on liver cancer in Africa |
|
Evaluation of tuberculosis diagnostics: establishing an evidence base around the public health impact |
|
F-18 FDG PET in the diagnosis and monitoring of salmonella vertebral osteomyelitis: a comparison with MRI. |
|
Genetics of susceptibility to human infectious disease |
|
The Global Burden of Cancer 2013 |
|
Global distribution and prevalence of hepatitis C virus genotypes |
|
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition |
|
Host genetics and the dissection of mycobacterial immunity. |
|
Impact of a novel molecular TB diagnostic system in patients at high risk of TB mortality in rural South Africa (Uchwepheshe): study protocol for a cluster randomised trial |
|
Impact of point-of-care CD4 testing on linkage to HIV care: a systematic review. |
|
Impact of Point-of-care Xpert MTB/RIF on Tuberculosis Treatment Initiation: A Cluster Randomised Trial. |
|
Implementation of HIV testing is patchy in the UK |
|
International spread of MDR TB from Tugela Ferry, South Africa |
|
Localized spatial clustering of HIV infections in a widely disseminated rural South African epidemic |
|
Low levels of HIV test coverage in clinical settings in the U.K.: a systematic review of adherence to 2008 guidelines |
|
Mapping of a novel susceptibility locus suggests a role for MC3R and CTSZ in human tuberculosis |
|
Medicine. Hepatitis C can be cured globally, but at what cost? |
|
Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice |
|
Need for timely paediatric HIV treatment within primary health care in rural South Africa |
|
New research and development strategy for tuberculosis diagnostics urgently needed. |
|
Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT |
|
Performance of Xpert MTB/RIF in the diagnosis of tuberculous mediastinal lymphadenopathy by endobronchial ultrasound |
|
A polymorphism that reduces RANTES expression is associated with protection from death in HIV-seropositive Ugandans with advanced disease |
|
Polymorphism within the interferon-gamma/receptor complex is associated with pulmonary tuberculosis |
|
Population uptake of antiretroviral treatment through primary care in rural South Africa |
|
Rapid molecular detection of rifampicin resistance facilitates early diagnosis and treatment of multi-drug resistant tuberculosis: case control study |
|
Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort |
|
Renal impairment in a rural African antiretroviral programme |
|
Response to Mallet et al., 'Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients' |
|
Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa |
|
S43 Polyfunctional T cells reveal the spectrum of tuberculosis in HIV co-infection through the identification of immunological correlates of latent and active disease |
|
Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP |
|
Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis. |
|
T-cell immunophenotyping distinguishes active from latent tuberculosis |
|
Technologies for global health |
|
Towards the WHO target of zero childhood tuberculosis deaths: an analysis of mortality in 13 locations in Africa and Asia |
|
Tracking the progress of HIV: the impact of point-of-care tests on antiretroviral therapy |
|
Transient bone marrow oedema syndrome in an HIV-infected patient on highly active antiretroviral therapy |
|
Treatment for hepatitis B. |
|
Treatment of cryptococcal meningitis in KwaZulu-Natal, South Africa |
|
Treatment outcomes of treatment-naïve Hepatitis C patients co-infected with HIV: a systematic review and meta-analysis of observational cohorts |
|
The tuberculosis challenge in a rural South African HIV programme |
|
Twin peaks: The Omicron SARS-CoV-2 BA.1 and BA.2 epidemics in England |
|
Update on tuberculosis: TB in the early 21st century |
|